Trials / Completed
CompletedNCT03953053
Safety and Efficacy of FLACS With the FEMTO LDV Z8 Laser Compared to Conventional Cataract Surgery in Chinese Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 132 (actual)
- Sponsor
- Ziemer Ophthalmic Systems AG · Industry
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This trial will be designed as a multi-center randomized non-inferiority clinical trial to demonstrate safety and efficacy of the FEMTO LDV Z8 laser for cataract surgery in a Chinese population in China compared to the conventional technique.
Detailed description
In this three center, prospective, interventional, randomized controlled study we aim to determine safety and efficacy of the FEMTO LDV Z8 laser as compared to conventional technique in Chinese patients diagnosed with cataract of any severity grade that are eligible to undergo cataract surgery with age 50 years and a maximum age of 80 years in China.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Femtosecond Laser Assissted Cataract Surgery | During routine Catarct Surgery the Femtolaser cuts a ACCC (Anterior Continous Curvilinear Capsulotomy) into the lensbag and fragmentise the cataract affilited lens body |
Timeline
- Start date
- 2019-06-03
- Primary completion
- 2020-06-04
- Completion
- 2020-06-04
- First posted
- 2019-05-16
- Last updated
- 2021-12-27
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03953053. Inclusion in this directory is not an endorsement.